Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial-Reference-Cited by-同舟云学术

Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial

Published:2022-09-23 Issue:10 Volume:24 Page:1928-1939
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Metra Marco¹,Jankowska Ewa A.²³,Pagnesi Matteo¹,Anker Stefan D.⁴,Butler Javed⁵,Dorigotti Fabio⁶,Fabien Vincent⁶,Filippatos Gerasimos⁷,Kirwan Bridget‐Anne⁸⁹,Macdougall Iain C.¹⁰,Rosano Giuseppe¹¹,Ruschitzka Frank¹²,Tomasoni Daniela¹,van der Meer Peter¹³,Ponikowski Piotr²,

Affiliation:

1. Insitute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia Brescia Italy

2. Institute of Heart Diseases Wroclaw Medical University Poland

3. Institute of Heart Diseases University Hospital Wroclaw Poland

4. Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin Berlin Germany

5. University of Mississippi Medical Center Jackson MS USA

6. Vifor Pharma Ltd Glattbrugg Switzerland

7. National and Kapodistrian University of Athens, School of Medicine Athens University Hospital Attikon, Department of Cardiology Athens Greece

8. Department of Clinical Research SOCAR Research SA Nyon Switzerland

9. London School of Hygiene and Tropical Medicine University College London London UK

10. Department of Renal Medicine King's College Hospital London UK

11. Centre for Clinical and Basic Research, Department of Medical Sciences IRCCS San Raffaele Pisana Rome Italy

12. Department of Cardiology, University Heart Center University Hospital Zürich and University of Zürich Zürich Switzerland

13. Department of Cardiology University Medical Center Groningen Groningen The Netherlands

Funder

Vifor Pharma

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2630

Reference29 articles.

1. The Burden of Iron Deficiency in Heart Failure

2. High prevalence of iron deficiency in patients with acute decompensated heart failure

3. Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up

4. Iron Deficiency in Heart Failure

5. Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of intravenous iron therapy in patients with heart failure and iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials;Journal of Cardiology;2024-02

2. Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING‐HF trial;Journal of Cachexia, Sarcopenia and Muscle;2024-01-15

3. The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure Registry;European Journal of Heart Failure;2024-01-08

4. The HF-ABCDE + FG approach in heart failure: a simplified decision-making algorithm for management in emergency department;European Heart Journal: Acute Cardiovascular Care;2023-12-11

5. The Effects of Therapy for Iron Deficiency in Patients With Different Etiologies of Heart Failure and Concomitant Diseases;Kardiologiia;2023-12-05